Microbiological equivalence of serum bacteriostatic and bactericidal activities of the sera from healthy volunteers receiving original meropenem (MeronemR) and generic meropenem (MeroR)

Journal of the Medical Association of Thailand

Volumn 93, Issue SUPPL 1, 2010, Pages

  Thamlikitkul, Visanu ^a   Tiengrim, Surapee ^a   Chalermsri, Chalobol ^a   Chinsawangwatanakul, Pornsiri ^a   Suddhichupaiboon, Siriluk ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Generic drug; Meropenem; Microbiological equivalence

Indexed keywords

ANTIINFECTIVE AGENT; GENERIC DRUG; MEROPENEM; THIENAMYCIN DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; PHARMACOKINETICS; RANDOMIZED CONTROLLED TRIAL; THAILAND;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIA; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUGS, GENERIC; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; SERUM BACTERICIDAL TEST; THAILAND; THERAPEUTIC EQUIVALENCY; THIENAMYCINS; YOUNG ADULT;

EID: 77951889701     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Baldwin CM, Lyseng-Williamson KA, Keam SJ. Meropenem: a review of its use in the treatment of serious bacterial infections. Drugs 2008; 68: 803-38.
2. Leelarasamee A, Rongrungruang Y, Trakulsomboon S, Pongpech P, Thanawattanawanich P, Jithavech P. Bioequivalence, antibacterial activity and therapeutic outcome of a generic meropenem (Mapenem). J Med Assoc Thai 2008; 91: 980-8.
3. Leelarasamee A, Sathirakul K, Trakulsomboon S, Pongpech P, Naenna P. Bioequivalence study with comparative antibacterial activity of a generic meropenem. J Infect Dis Antimicrob Agents 2008; 25: 63-72.
4. Zuluaga AF, Agudelo M, Rodriguez CA, Vesga O. Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics. BMC Clin Pharmacol 2009; 9: 1.
5. Sculier JP, Klastersky J. Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia. Am J Med 1984; 76: 429-35.
6. Weinstein MP, Stratton CW, Ackley A, Hawley HB, Robinson PA, Fisher BD, et al. Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med 1985; 78: 262-9.
7. Martino P, Venditti M, Valente B, Mandelli F, Serra P. Serum bactericidal activity as a therapeutic guide in severely granulocytopenic patients with gramnegative septicemia. Eur J Cancer Clin Oncol 1985; 21: 439-45.
8. Weinstein MP, Stratton CW, Hawley HB, Ackley A, Reller LB. Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis. Am J Med 1987; 83: 218-22.
9. Liao CH, Sheng WH, Chen YC, Hung CC, Wang JT, Chang SC. Predictive value of the serum bactericidal test for mortality in patients infected with multidrug-resistant Acinetobacter baumannii. J Infect 2007; 55: 149-57.
10. Eykyn SJ. The role of the laboratory in assisting treatment-a review of current UK practices. J Antimicrob Chemother 1987; 20 (Suppl A): 51-70.
11. Jaruratanasirikul S, Sriwiriyajan S, Punyo J. Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection. Antimicrob Agents Chemother 2005; 49: 1337-9.
12. Lorente L, Lorenzo L, Martin MM, Jimenez A, Mora ML. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli. Ann Pharmacother 2006; 40: 219-23.